Pollack SJ - Search Results

1

Secretase inhibitors for Alzheimer's disease: challenges of a promiscuous protease.

Pollack SJ, Lewis H. Pollack SJ, et al. Curr Opin Investig Drugs. 2005 Jan;6(1):35-47. Curr Opin Investig Drugs. 2005. PMID: 15675602 Review.

2

Catalytic site-directed gamma-secretase complex inhibitors do not discriminate pharmacologically between Notch S3 and beta-APP cleavages.

Lewis HD, Pérez Revuelta BI, Nadin A, Neduvelil JG, Harrison T, Pollack SJ, Shearman MS. Lewis HD, et al. Among authors: pollack sj. Biochemistry. 2003 Jun 24;42(24):7580-6. doi: 10.1021/bi034310g. Biochemistry. 2003. PMID: 12809514

3

Sulphated compounds attenuate beta-amyloid toxicity by inhibiting its association with cells.

Sadler II, Smith DW, Shearman MS, Ragan CI, Tailor VJ, Pollack SJ. Sadler II, et al. Among authors: pollack sj. Neuroreport. 1995 Dec 29;7(1):49-53. Neuroreport. 1995. PMID: 8742414

4

The toxicity in vitro of beta-amyloid protein.

Iversen LL, Mortishire-Smith RJ, Pollack SJ, Shearman MS. Iversen LL, et al. Among authors: pollack sj. Biochem J. 1995 Oct 1;311 ( Pt 1)(Pt 1):1-16. doi: 10.1042/bj3110001. Biochem J. 1995. PMID: 7575439 Free PMC article. Review. No abstract available.

5

Sulfated glycosaminoglycans and dyes attenuate the neurotoxic effects of beta-amyloid in rat PC12 cells.

Pollack SJ, Sadler II, Hawtin SR, Tailor VJ, Shearman MS. Pollack SJ, et al. Neurosci Lett. 1995 Jan 23;184(2):113-6. doi: 10.1016/0304-3940(94)11182-i. Neurosci Lett. 1995. PMID: 7724043

6

Inositol monophosphatase--a putative target for Li+ in the treatment of bipolar disorder.

Atack JR, Broughton HB, Pollack SJ. Atack JR, et al. Among authors: pollack sj. Trends Neurosci. 1995 Aug;18(8):343-9. doi: 10.1016/0166-2236(95)93926-o. Trends Neurosci. 1995. PMID: 7482796 Review.

7

Structure and mechanism of inositol monophosphatase.

Atack JR, Broughton HB, Pollack SJ. Atack JR, et al. Among authors: pollack sj. FEBS Lett. 1995 Mar 13;361(1):1-7. doi: 10.1016/0014-5793(95)00063-f. FEBS Lett. 1995. PMID: 7890024 Free article. Review.

8

Sulfonated dyes attenuate the toxic effects of beta-amyloid in a structure-specific fashion.

Pollack SJ, Sadler II, Hawtin SR, Tailor VJ, Shearman MS. Pollack SJ, et al. Neurosci Lett. 1995 Sep 15;197(3):211-4. doi: 10.1016/0304-3940(95)11939-t. Neurosci Lett. 1995. PMID: 8552301

9

Substituting c-Jun N-terminal kinase-3 (JNK3) ATP-binding site amino acid residues with their p38 counterparts affects binding of JNK- and p38-selective inhibitors.

Fricker M, Lograsso P, Ellis S, Wilkie N, Hunt P, Pollack SJ. Fricker M, et al. Among authors: pollack sj. Arch Biochem Biophys. 2005 Jun 15;438(2):195-205. doi: 10.1016/j.abb.2005.04.013. Arch Biochem Biophys. 2005. PMID: 15907786

10

Small molecule Trk receptor agonists and other neurotrophic factor mimetics.

Pollack SJ, Harper SJ. Pollack SJ, et al. Curr Drug Targets CNS Neurol Disord. 2002 Feb;1(1):59-80. doi: 10.2174/1568007023339490. Curr Drug Targets CNS Neurol Disord. 2002. PMID: 12769635 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters